keyword
https://read.qxmd.com/read/38642915/trilobatin-regulates-glucose-metabolism-by-ameliorating-oxidative-stress-and-insulin-resistance-in-vivo-and-in-vitro
#21
JOURNAL ARTICLE
Ming He, Yuqing Zhang, Yuhan Zhai, Yaping Li, Guorui Yang, Shaoxuan Yu, Haifang Xiao, Yuanda Song
OBJECTIVES: Trilobatin, a glycosylated dihydrochalcone, has been reported to have anti-diabetic properties. However, the underlying mechanism remains unexplained. METHODS: In this investigation, the regulation of trilobatin on glucose metabolism of insulin resistance (IR)-HepG2 cells and streptozocin (STZ)-induced mice and its mechanism were evaluated. KEY FINDINGS: Different doses of trilobatin (5, 10 and 20 μM) increased glucose consumption, glycogen content, hexokinase (HK), and pyruvate kinase (PK) activity in IR-HepG2 cells...
April 20, 2024: Journal of Pharmacy and Pharmacology
https://read.qxmd.com/read/38642860/intermittently-scanned-continuous-glucose-monitoring-provides-no-benefit-over-structured-self-monitoring-of-blood-glucose-in-type-2-diabetes-not-on-prandial-insulin-in-the-context-of-diabetes-self-management-education-glucose-monitoring-programme-singapore
#22
JOURNAL ARTICLE
Suresh Rama Chandran, Nabilah Rahman, Mihir Gandhi, Ngiap Chuan Tan, Ian K Y Phoon, Darren E J Seah, Ming Hann Cheah, Kathleen Sek, Daphne Su-Lyn Gardner
OBJECTIVE: We evaluated the impact of intermittently scanned continuous glucose monitoring(is-CGM)over self-monitoring of blood glucose(SMBG) in the context of diabetes self-management education (DSME) in sub-optimally controlled type 2 diabetes(T2D) in a multi-ethnicsetting. RESEARCH DESIGN AND METHOD: Randomized-controlled, open-label trial (NCT04564911), of T2D with HbA1c ≥ 7.5-≤10 %, on oral agents with/without basal insulin was carried out...
April 18, 2024: Diabetes Research and Clinical Practice
https://read.qxmd.com/read/38642828/virus-induced-diabetes-mellitus-revisiting-infection-etiology-in-light-of-sars-cov-2
#23
REVIEW
Sundararaj Stanleyraj Jeremiah, Abu Saleh Md Moin, Alexandra E Butler
Diabetes mellitus (DM) is comprised of two predominant subtypes: type 1 diabetes mellitus (T1DM), accounting for approximately 5 % of cases worldwide and resulting from autoimmune destruction of insulin-producing β-cells, and type 2 (T2DM), accounting for approximately 95 % of cases globally and characterized by the inability of pancreatic β-cells to meet the demand for insulin due to a relative β-cell deficit in the setting of peripheral insulin resistance. Both types of DM involve derangement of glucose metabolism and are metabolic diseases generally considered to be initiated by a combination of genetic and environmental factors...
April 18, 2024: Metabolism: Clinical and Experimental
https://read.qxmd.com/read/38642825/effect-of-metformin-in-hypothalamic-astrocytes-from-an-immunocompromised-mice-model
#24
JOURNAL ARTICLE
Larissa Daniele Bobermin, Daniele Schauren da Costa, Aline Daniel Moreira de Moraes, Vanessa Fernanda da Silva, Giancarlo Tomazzoni de Oliveira, Patrícia Sesterheim, Ana Carolina Tramontina, Luiz Augusto Basso, Guilhian Leipnitz, André Quincozes-Santos, Carlos-Alberto Gonçalves
Astrocytes are glial cells that play key roles in neuroinflammation, which is a common feature in diabetic encephalopathy and aging process. Metformin is an antidiabetic compound that shows neuroprotective properties, including in inflammatory models, but astroglial signaling pathways involved are still poorly known. Interferons α/β are cytokines that participate in antiviral responses and the lack of their signaling increases susceptible to viral infections. Here, we investigated the effects of metformin on astrocytes from hypothalamus, a crucial brain region related to inflammatory processes...
April 18, 2024: Biochimie
https://read.qxmd.com/read/38642823/effect-of-non-surgical-periodontal-therapy-on-hemoglobin-a1c-in-periodontitis-patients-without-diabetes-mellitus-a-systematic-review-and-meta-analysis
#25
REVIEW
Yangyang Sun, Weijia Zhang, Lijie Lu, Dan Zhao, Songlin Wang, Yaping Pan, Chen Li
OBJECTIVES: This systematic review was aimed to evaluate the effect of non-surgical periodontal therapy (NSPT) on hemoglobin A1c (HbA1c) in periodontitis patients without diabetes mellitus (DM). DATA/SOURCES: The present systematic review and meta-analysis were performed through searching the following electronic databases: EMBASE, MEDLINE, Web of Science, Cochrane Library and Open GREY. Interventional studies of periodontitis patients without DM were investigated...
April 18, 2024: Journal of Dentistry
https://read.qxmd.com/read/38642795/nanoparticle-mediated-delivery-of-tetrahydrobiopterin-restores-endothelial-function-in-diabetic-rats
#26
JOURNAL ARTICLE
Katherine A Kelly, Cristine L Heaps, Guoyao Wu, Vinod Labhasetwar, Cynthia J Meininger
Endothelial dysfunction, underlying the vascular complications of, may result from uncoupling of endothelial nitric oxide synthase (eNOS) activity due to decreased levels of tetrahydrobiopterin (BH4), a critical co-factor for eNOS. Some clinical trials attempting to deliver exogenous BH4 as a potential therapeutic strategy in vascular disease states have failed due to oxidation of BH4 in the circulation. We sought to develop a means of protecting BH4 from oxidation while delivering it to dysfunctional endothelial cells...
April 18, 2024: Nitric Oxide: Biology and Chemistry
https://read.qxmd.com/read/38642691/ganoderma-lucidum-multifaceted-mechanisms-to-combat-diabetes-through-polysaccharides-and-triterpenoids-a-comprehensive-review
#27
REVIEW
Md Faruque Ahmad, Fakhruddin Ali Ahmad, Nazim Hasan, Abdulrahman A Alsayegh, Othman Hakami, Farkad Bantun, Shadma Tasneem, Waleed M Alamie, Ahmad O Babalghith, Abdullah F Aldairi, Nahla Kambal, Ehab Y Elbendary
Diabetes is a chronic metabolic disorder. Diabetes complications can affect many organs and systems in the body. Ganoderma lucidum (G. lucidum) contains various compounds that have been studied for their potential antidiabetic effects, including polysaccharides, triterpenoids (ganoderic acids, ganoderol B), proteoglycans, and G. lucidum extracts. G. lucidum polysaccharides (GLPs) and triterpenoids have been shown to act through distinct mechanisms, such as improving glucose metabolism, modulating the mitogen-activated protein kinase (MAPK) system, inhibiting the nuclear factor-kappa B (NF-κB) pathway, and protecting the pancreatic beta cells...
April 18, 2024: International Journal of Biological Macromolecules
https://read.qxmd.com/read/38642668/gastrodin-alleviates-the-deterioration-of-depressive-like-behavior-and-glucolipid-metabolism-promoted-by-chronic-stress-in-type-2-diabetic-mice
#28
JOURNAL ARTICLE
Canye Li, Jinming Cao, Zhicong Chen, Zuanjun Su, Huimin Bao, Xue Li, Luping Liu, Zhijun Xiao, Jingjing Duan, Ting Zhou, Feng Xu
The growing burden of psychological stress among diabetes patients has contributed to a rising incidence of depression within this population. It is of significant importance to conduct research on the impact of stress on diabetes patients and to explore potential pharmacological interventions to counteract the stress-induced exacerbation of their condition. Gastrodin is a low molecular weight bioactive compound extracted from the rhizome of Gastrodiae elata Blume, and it may be a preventive strategy for diabetes and a novel treatment for depression symptoms...
April 18, 2024: European Journal of Pharmacology
https://read.qxmd.com/read/38642640/sex-specific-associations-of-environmental-exposures-with-prevalent-diabetes-and-obesity-results-from-the-kora-fit-study
#29
JOURNAL ARTICLE
Fiona Niedermayer, Kathrin Wolf, Siqi Zhang, Marco Dallavalle, Nikolaos Nikolaou, Lars Schwettmann, Peter Selsam, Barbara Hoffmann, Alexandra Schneider, Annette Peters
BACKGROUND: Promising evidence suggests a link between environmental factors, particularly air pollution, and diabetes and obesity. However, it is still unclear whether men and women are equally susceptible to environmental exposures. OBJECTIVES: We aimed to assess sex-specific long-term effects of environmental exposures on metabolic diseases. METHODS: We analyzed cross-sectional data from 3,034 participants (53.7% female, aged 53-74 years) from the KORA Fit study (2018/19), a German population-based cohort...
April 18, 2024: Environmental Research
https://read.qxmd.com/read/38642631/inhibition-of-hdac6-with-cay10603-alleviates-acute-and-chronic-kidney-injury-by-suppressing-the-atf6-branch-of-upr
#30
JOURNAL ARTICLE
Shuyan Kan, Qing Hou, Ruixiang Yang, Fan Yang, Mingchao Zhang, Zhihong Liu, Song Jiang
BACKGROUND: histone deacetylase 6 (HDAC6) inhibitor CAY10603 has been identified as a potential therapeutic agent for the treatment of diabetic kidney disease (DKD). The objective of this study was to investigate the therapeutic effects of CAY10603 in mice with acute kidney injury (AKI) and chronic kidney diseases (CKD). METHODS: Renal immunohistology was performed to assess expression level of HDAC6 in both human and mouse kidney samples. C57BL/6J mice were intraperitoneal injected with lipopolysaccharide (LPS) to induce AKI; CD-1 mice were fed with adenine diet to induce adenine-nephropathy as CKD model...
April 18, 2024: Archives of Biochemistry and Biophysics
https://read.qxmd.com/read/38642630/hook-effect-in-maglumi-immunoassay-for-serum-anti-gad-antibodies-in-neurological-disorders-when-wrong-matrix-is-the-right-choice
#31
G Musso, M Zoccarato, N Gallo, M Plebani, D Basso
Antibodies against glutamic acid decarboxylase (anti-GAD) are a valuable diagnostic tool to detect severe autoimmune conditions as type 1 diabetes mellitus (T1DM) and anti-GAD related neurological disorders, having the latter more often anti-GAD concentrations in serum multiple times higher than in the former. Automated immunoassays, either with ELISA or chemiluminescent technology, are validated for diagnostic use in serum with analytical ranges suitable for T1DM diagnosis. In a patient presenting with a suspected autoimmune ataxia, anti-GAD testing on an automated chemiluminescent immunoassay (CLIA) resulted in slightly abnormal concentrations in serum (39...
April 18, 2024: Clinica Chimica Acta; International Journal of Clinical Chemistry
https://read.qxmd.com/read/38642589/dose-dependent-effect-of-aspirin-use-in-reducing-diabetes-associated-dementia-risk-among-elderly-patients-with-type-2-diabetes-mellitus
#32
JOURNAL ARTICLE
Mingyang Sun, Wan-Ming Chen, Szu-Yuan Wu, Jiaqiang Zhang
OBJECTIVE: This study investigated the association between aspirin use and diabetes-associated dementia in older patients with type 2 diabetes mellitus (T2DM), assessing aspirin's potential protective effects, intensity of use, and dose-dependency against dementia. DESIGN: A cohort study evaluating the dose-dependent protective impact of aspirin against dementia in a population-based sample. SETTING AND PARTICIPANTS: Older patients with T2DM (≥60 years), comparing aspirin users with nonusers...
April 18, 2024: Journal of the American Medical Directors Association
https://read.qxmd.com/read/38642585/the-emerging-role-of-glucagon-like-peptide-1-in-binge-eating
#33
REVIEW
Katherine N Balantekin, Martin J Kretz, Elizabeth G Mietlicki-Baase
Binge eating is a central component of two clinical eating disorders, binge eating disorder and bulimia nervosa, but the large treatment gap highlights the need to identify other strategies to decrease binge eating. Novel pharmacotherapies may be one such approach. Glucagon-like peptide-1 (GLP-1) is an intestinal and brain-derived neuroendocrine signal with a critical role in promoting glycemic control through its incretin effect. Additionally, the energy balance effects of GLP-1 are well-established; activation of the GLP-1 receptor (GLP-1R) reduces food intake and body weight...
April 1, 2024: Journal of Endocrinology
https://read.qxmd.com/read/38642584/an-adipocentric-perspective-of-pancreatic-lipotoxicity-in-diabetes-pathogenesis
#34
REVIEW
Renata Risi, Antonio J Vidal-Puig, Guillaume Bidault
Obesity and diabetes represent two increasing and invalidating public health issues that often coexist. It is acknowledged that fat mass excess predisposes to insulin resistance and type 2 diabetes mellitus (T2D), with the increasing incidence of the two diseases significantly associated. Moreover, emerging evidence suggests that obesity might also accelerate the appearance of type 1 diabetes (T1D), which is now a relatively frequent comorbidity in patients with obesity. It is a common clinical finding that not all patients with obesity will develop diabetes at the same level of adiposity, with gender, genetic, and ethnic factors playing an important role in defining the timing of diabetes appearance...
April 1, 2024: Journal of Endocrinology
https://read.qxmd.com/read/38642582/a-challenging-case-of-a-pituitary-macroadenoma-and-toxic-thyroid-adenoma-with-inappropriate-tsh-secretion
#35
JOURNAL ARTICLE
Michaela Despina Carides, Ruchika Mehta, Jaco Louw, Farzahna Mohamed
SUMMARY: Thyroid-stimulating hormone-secreting pituitary adenomas (TSHomas) are rare, accounting for less than 1% of all pituitary adenomas. We present a case of hyperthyroidism secondary to a likely TSHoma and coexisting functional thyroid adenoma. Laboratory errors and familial abnormalities in thyroid function tests were ruled out, and a diagnosis of the toxic thyroid adenoma was confirmed on a thyroid uptake scan. However, the triiodothyronine suppression test was contraindicated due to the patient's cardiovascular disease, and the thyrotropin-releasing hormone stimulation test, measurement of glycoprotein hormone alpha-subunit, and genetic testing were unavailable...
April 1, 2024: Endocrinology, Diabetes & Metabolism Case Reports
https://read.qxmd.com/read/38642577/challenging-diagnosis-of-resistance-to-thyroid-hormone-in-a-patient-with-covid-19-pituitary-microadenoma-and-unusual-response-to-octreotide-long-acting-release-test
#36
JOURNAL ARTICLE
Cristian Petolicchio, Sara Brasili, Stefano Gay, Francesco Cocchiara, Irene Campi, Luca Persani, Lara Vera, Diego Ferone, Federico Gatto
SUMMARY: The resistance to thyroid hormone syndrome (RTHβ) occurs uncommonly and requires a high level of clinical suspicion and specific investigations to reach a precise diagnosis and to avoid unnecessary and potentially harmful therapies. We report a case of a young male patient referred to our unit for SARS-CoV-2 infection and atrial fibrillation with elevated thyroid hormones and non-suppressed thyroid-stimulating hormone (TSH), for which antithyroid therapy was prescribed...
April 1, 2024: Endocrinology, Diabetes & Metabolism Case Reports
https://read.qxmd.com/read/38642570/global-incidence-prevalence-years-lived-with-disability-ylds-disability-adjusted-life-years-dalys-and-healthy-life-expectancy-hale-for-371-diseases-and-injuries-in-204-countries-and-territories-and-811-subnational-locations-1990-2021-a-systematic-analysis-for
#37
JOURNAL ARTICLE
(no author information available yet)
BACKGROUND: Detailed, comprehensive, and timely reporting on population health by underlying causes of disability and premature death is crucial to understanding and responding to complex patterns of disease and injury burden over time and across age groups, sexes, and locations. The availability of disease burden estimates can promote evidence-based interventions that enable public health researchers, policy makers, and other professionals to implement strategies that can mitigate diseases...
April 15, 2024: Lancet
https://read.qxmd.com/read/38642556/modification-of-coronary-artery-disease-clinical-risk-factors-by-coronary-artery-disease-polygenic-risk-score
#38
JOURNAL ARTICLE
Buu Truong, Yunfeng Ruan, Sara Haidermota, Aniruddh Patel, Ida Surakka, Whitney Hornsby, Satoshi Koyama, S Hong Lee, Pradeep Natarajan
BACKGROUND: The extent to which the relationships between clinical risk factors and coronary artery disease (CAD) are altered by CAD polygenic risk score (PRS) is not well understood. Here, we determine whether the interactions between clinical risk factors and CAD PRS further explain risk for incident CAD. METHODS: Participants were of European ancestry from the UK Biobank without prevalent CAD. An externally trained genome-wide CAD PRS was generated and then applied...
March 21, 2024: Med
https://read.qxmd.com/read/38642547/obesity-differs-from-diabetes-mellitus-in-antibody-and-t-cell-responses-post-covid-19-recovery
#39
JOURNAL ARTICLE
Mohammad Ali, Stephanie Longet, Isabel Neale, Patpong Rongkard, Forhad Uddin Hassan Chowdhury, Jennifer Hill, Anthony Brown, Stephen Laidlaw, Tom Tipton, Ashraful Hoque, Nazia Hassan, Carl-Philipp Hackstein, Sandra Adele, Hossain Delowar Akther, Priyanka Abraham, Shrebash Paul, Md Matiur Rahman, Md Masum Alam, Shamima Parvin, Forhadul Hoque Mollah, Md Mozammel Hoque, Shona C Moore, Subrata K Biswas, Lance Turtle, Thushan I de Silva, Ane Ogbe, John Frater, Eleanor Barnes, Adriana Tomic, Miles W Carroll, Paul Klenerman, Barbara Kronsteiner, Fazle Rabbi Chowdhury, Susanna J Dunachie
Obesity and type 2 diabetes (DM) are risk factors for severe COVID-19 outcomes, which disproportionately affect South Asian populations. This study aims to investigate the humoral and cellular immune responses to SARS-CoV-2 in adult COVID-19 survivors with obesity and DM in Bangladesh. In this cross-sectional study, SARS-CoV-2-specific antibody and T cell responses were investigated in 63 healthy and 75 PCR-confirmed COVID-19 recovered individuals in Bangladesh, during the pre-vaccination first wave of the COVID-19 pandemic in 2020...
April 20, 2024: Clinical and Experimental Immunology
https://read.qxmd.com/read/38642541/risk-of-revision-total-knee-arthroplasty-for-patients-with-prior-bariatric-surgery-or-class-iii-obesity
#40
JOURNAL ARTICLE
Sanjay Kubsad, Laurie Bracey, Amil R Agarwal, Majd Marrache, Alex Gu, Jordan S Cohen, Savyasachi C Thakkar, Gregory J Golladay
BACKGROUND: Bariatric surgery (BS) is indicated for select class III obesity patients undergoing total knee arthroplasty (TKA) to reduce obesity-related complications. This study assessed the effect of BS on TKA revision rates compared to the general population and class III obesity patients without a history of BS. METHODS: A national database identified patients who had primary TKA. They were divided into two groups: those with BS prior to TKA and those without...
April 19, 2024: Knee
keyword
keyword
11388
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.